117 related articles for article (PubMed ID: 26372394)
1. IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.
Real LM; Herrero R; Rivero-Juárez A; Camacho Á; Macías J; Vic S; Soriano V; Viedma S; Guardiola JM; Fibla J; Rivero A; Pineda JA; Caruz A
AIDS; 2015 Sep; 29(14):1895-7. PubMed ID: 26372394
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
3. A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection.
Jaimes-Bernal C; Rallón N; Benito JM; Omar M; Gómez-Vidal MA; Márquez FJ; Sánchez-Arcas B; Trujillo M; Royo JL; Saulle I; Biasin M; Rivero-Juárez A; Caruz A
J Infect Dis; 2019 Feb; 219(5):772-776. PubMed ID: 30289470
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
5. A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.
Pouryasin M; Sharafi H; Behnava B; Alavian SM; Keshvari M; Pouryasin A
Lab Med; 2017 Feb; 48(1):51-56. PubMed ID: 28057801
[TBL] [Abstract][Full Text] [Related]
6.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
7. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
[TBL] [Abstract][Full Text] [Related]
8. Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C.
Krämer B; Nischalke HD; Boesecke C; Ingiliz P; Voigt E; Mauss S; Stellbrink HJ; Baumgarten A; Rockstroh JK; Spengler U; Nattermann J
AIDS; 2013 Nov; 27(17):2817-9. PubMed ID: 23939236
[TBL] [Abstract][Full Text] [Related]
9. IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.
Monteleone K; Scheri GC; Statzu M; Selvaggi C; Falasca F; Giustini N; Mezzaroma I; Turriziani O; d'Ettorre G; Antonelli G; Scagnolari C
Arch Virol; 2016 Nov; 161(11):3263-8. PubMed ID: 27558125
[TBL] [Abstract][Full Text] [Related]
10. IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals.
Machmach K; Abad-Molina C; Romero-Sánchez MC; Dominguez-Molina B; Moyano M; Rodriguez MM; Rafii-El-Idrissi Benhnia M; Jimenez-Mejias ME; Vidal F; Muñoz-Fernández MA; Genebat M; Viciana P; González-Escribano MF; Leal M; Ruiz-Mateos E
Clin Microbiol Infect; 2015 Mar; 21(3):289.e1-4. PubMed ID: 25658540
[TBL] [Abstract][Full Text] [Related]
11. Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs.
Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Toompere K; Lutsar I; Huik K
J Med Virol; 2018 Nov; 90(11):1779-1783. PubMed ID: 29992584
[TBL] [Abstract][Full Text] [Related]
12. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
Aka PV; Kuniholm MH; Pfeiffer RM; Wang AS; Tang W; Chen S; Astemborski J; Plankey M; Villacres MC; Peters MG; Desai S; Seaberg EC; Edlin BR; Strickler HD; Thomas DL; Prokunina-Olsson L; Sharp GB; O'Brien TR
J Infect Dis; 2014 Feb; 209(3):350-4. PubMed ID: 23956438
[TBL] [Abstract][Full Text] [Related]
13. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
[TBL] [Abstract][Full Text] [Related]
14. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
Fang MZ; Jackson SS; Pfeiffer RM; Kim EY; Chen S; Hussain SK; Jacobson LP; Martinson J; Prokunina-Olsson L; Thio CL; Duggal P; Wolinsky S; O'Brien TR
Clin Infect Dis; 2023 Feb; 76(3):521-527. PubMed ID: 36573283
[TBL] [Abstract][Full Text] [Related]
15. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
16. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
[TBL] [Abstract][Full Text] [Related]
17. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR
PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156
[TBL] [Abstract][Full Text] [Related]
18. Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study).
Ghosn J; Fouquet B; Quertainmont Y; Salmon D; Sahali S; Rioux C; Duvivier C; Mole M; Delfraissy JF; Misrahi M
J Med Virol; 2015 Apr; 87(4):619-24. PubMed ID: 25611191
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
[TBL] [Abstract][Full Text] [Related]
20. A SDF1 genetic variant confers resistance to HIV-1 infection in intravenous drug users in China.
Gong X; Liu Y; Liu FL; Jin L; Wang H; Zheng YT
Infect Genet Evol; 2015 Aug; 34():137-42. PubMed ID: 26168882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
